临床研究

中老年肠道炎性肌纤维母细胞瘤临床病理及预后特点

  • 谭敏华 ,
  • 陈威 ,
  • 郭锦辉 ,
  • 周泳健 ,
  • 雷伟华 ,
  • 刘慕诗 ,
  • 申动 ,
  • 申洪
展开
  • 1.肇庆市第一人民医院病理科 (广东 肇庆 526060 )
    2.华南理工大学医学院 (广州 510000 )
    3.南方医科大学公共卫生学院 (广州 510515 )
    4.南方医科大学南方医院病理科/基础医学院病理学系 (广州 510515 )

收稿日期: 2023-08-22

  网络出版日期: 2024-03-08

基金资助

广东省科技计划项目(2010B060300001);肇庆市科技创新指导类项目(201704031411)

Clinicopathological and prognostic characteristics of intestinal inflammatory myofibroblastic tumor in middle⁃aged and elderly patients

  • Minhua TAN ,
  • Wei CHEN ,
  • Jinhui GUO ,
  • Yongjian ZHOU ,
  • Weihua LEI ,
  • Mushi LIU ,
  • Dong SHEN ,
  • Hong. SHEN
Expand
  • *.Department of Pathology,the First People's Hospital of Zhaoqing,Zhaoqing 526060,China

Received date: 2023-08-22

  Online published: 2024-03-08

摘要

目的 探讨中老年肠道炎性肌纤维母细胞瘤(inflammatory myofibroblastic tumours, IMT)的临床病理及预后特点。 方法 回顾性分析5例中老年肠道IMT的临床、病理形态、免疫表型及随访结果。 结果 4例IMT发生在右半结肠,1例在回肠。3/5患者有肠道损伤史,首发消化道症状且白细胞增高。瘤组织由梭形肌纤维母细胞和纤维母细胞构成,席纹状排列,浸润性生长,伴较多淋巴细胞、浆细胞浸润,可见胶原化及黏液水肿。其中一例异型性明显,核大且畸形。免疫表型:瘤细胞vimentin(5例)、SMA(5例)、desmin(3例)、ALK(3例)、CK(2例)阳性,Caldesmon、CD34、β-catenin、MC、CD117、DOG1、S-100、BCL-2、CD99、CD68均阴性,Ki-67增殖指数1.28% ~ 10.01%。5例均完整切除肿瘤,随访53 ~ 137.5个月,其中1例83岁患者,于术后27个月影像学考虑肿瘤复发;另一例术后无瘤生存122个月,因其他原因去世;其余均无瘤生存,基本状况良好。 结论 (1)本组中老年肠道IMT多见于右半结肠,多有肠道损伤史,多首发消化道症状,白细胞多升高;(2)Vimentin和SMA同时阳性,多伴ALK阳性;(3)4/5的患者手术切除治疗效果好,1/5的患者术后2 ~ 3年可复发;高龄且ALK阳性、Ki67达10%、异型性明显很有可能是中老年肠道IMT复发的重要危险因素,其中ALK阳性者复发的风险或许为1/3。

本文引用格式

谭敏华 , 陈威 , 郭锦辉 , 周泳健 , 雷伟华 , 刘慕诗 , 申动 , 申洪 . 中老年肠道炎性肌纤维母细胞瘤临床病理及预后特点[J]. 实用医学杂志, 2024 , 40(4) : 503 -507 . DOI: 10.3969/j.issn.1006-5725.2024.04.011

Abstract

Objective To investigate the clinicopathological and prognostic characteristics of intestinal inflammatory myofibroblastic tumours (IMT) in middle?aged and elderly patients. Methods The clinical, pathological morphology, immunophenotype and follow?up results of 5 cases of intestinal IMT in middle?aged and elderly patients were retrospectively analyzed. Results 4 cases of IMT occurred in the right half colon and 1 in the ileum. Most patients (3/5) had a history of intestinal injury, starting the digestive tract symptoms and increased leukocytes. The tumor tissue was composed of fusiform myofibroblasts and fibroblasts arranged in storiform pattern, with an infiltrative growth pattern, accompanied by a large number of lymphocytes and plasma cells infiltration, collagen formation and myxedema. One case was atypically large and deformed. Immunophenotype: vimentin (5cases), SMA (5 cases), desmin (3 cases), ALK (3 cases), CK (2 cases) were positive. Caldesmon, CD34, β?catenin, MC, CD117, DOG1, S?100, BCL?2, CD99, CD68 were negative, and Ki?67 proliferation index was 1.28% to 10.01%. All the 5 cases underwent complete tumor resection and were followed up for 48.5 to 133 months. Among them, 1 patient aged 83 was considered to have tumor recurrence 27 months after surgery. The other patient survived 122 months without tumor and died of other causes. All the others survived without tumor and were in good condition. Conclusion (1) Intestinal IMT in the middle?aged and elderly people in this group was more common in the right half colon, and most of them had a history of intestinal injury, first gastrointestinal symptoms and elevated white blood cells; (2)Vimentin and SMA were positive at the same time, and ALK was more positive; (3)4/5 patients had good surgical resection, and 1/5 patients could relapse 2 ~ 3 years after surgery; old age, ALK?positive, Ki67 up to 10%, atypia may be an important risk factor for intestinal IMT recurrence in the elderly, of which ALK?positive patients may have a recurrence risk of 1/3.

参考文献

1 classification of tumours WHO. Soft tissue and bone tumours [M]. Lyon: IARC Press, 2020:109-111.
2 沈涤华, 施诚仁, 葛莉,等. 儿童腹腔炎性肌纤维母细胞瘤5例报告[J]. 实用医学杂志, 2006, 22(5):556-558. doi:10.3969/j.issn.1006-5725.2006.05.028
3 GROS L, TOS A P D, JONES R L, et al. Inflammatory myofibroblastic tumour: state of the art[J]. Cancers, 2022, 14(15):3662. doi:10.3390/cancers14153662
4 SIEMION K, RESZEC-GIELAZYN J, KISLUK J, et al. What do we know about inflammatory myofibroblastic tumors? A systematic review[J]. Adv Med Sci, 2022,67:129-138. doi:10.1016/j.advms.2022.02.002
5 KARAISLI S, KAMER E, EKINCI N, et al. Inflammatory myofibroblastic tumour of the colon: 2 case reports and a comprehensive review of the literature[J]. Int J Colorectal Dis, 2020, 35(5):947-958. doi:10.1007/s00384-020-03522-0
6 COFFIN C M, WATTERSON J, PRIEST J R, et al. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases[J]. Am J Surg Pathol, 1995,19(8):859-872. doi:10.1097/00000478-199508000-00001
7 PATNANA M, SEVRUKOV A B, ELSAYES K M, et al. Inflammatory pseudotumor: the great mimicker[J]. AJR Am J Roentgenol, 2012,198(3):W217-W227. doi:10.2214/ajr.11.7288
8 COELHO V V, SURENDRAN S, ROOPAVATHANA B, et al. Colonic inflammatory myofibroblastic tumour presenting as ‘pyrexia of unknown origin’: report of a rare disease and its unique presentation[J]. BMJ Case Rep, 2020,13:e236056. doi:10.1136/bcr-2020-236056
9 MOHAMMAD HOSEINI-AZAR M, MOKHTARE M, ZARE-MIRZAIE A, et al. Fever, weight loss and early satiety due to gastric inflammatory myofibroblastic tumor. case report and literature review[J]. Middle East J Dig Dis, 2016,8(2):138-142. doi:10.15171/mejdd.2016.19
10 HORNICK J L, SHOLL L M, CIN P D, et al. Expression of ROS1 predicts ROS1 gene rearrangement in iflammatory myofibroblastic tumors[J]. Mod Pathol, 2015, 28(5):732-739. doi:10.1038/modpathol.2014.165
11 LOVLY C M, GUPTA A, LIPSON D, et al. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions[J]. Cancer Discov, 2014,4(8):889-895. doi:10.1158/2159-8290.cd-14-0377
12 丁茹,盛少洁,贡其星. 炎性肌纤维母细胞瘤的分子遗传学研究进展[J]. 中华病理学杂志, 2021, 50(12):1415-1418. doi:10.3760/cma.j.cn112151-20210723-00527
13 齐淑轶,邓莅霏,蔡勇. 肺外炎性肌纤维母细胞瘤9例临床病理学观察[J].实用医学杂志, 2017,33(23): 4013-4015. doi:10.3969/j.issn.1006-5725.2017.23.043
14 朱岩, 丁颖, 宋国新, 等. 炎性肌纤维母细胞肿瘤临床病理学分析[J]. 中华病理学杂志, 2021, 50(3):194-200. doi:10.3760/cma.j.cn112151-20200806-00627
15 张娣, 李德才, 黄架旗, 等. 直肠炎性肌纤维母细胞瘤一例报告并文献复习[J]. 中华肿瘤防治杂志, 2019, 26(15):1411-1144.
16 王秋鹏,甘梅富,张建伟,等. 胃肠道炎性肌纤维母细胞瘤的临床病理学分析[J]. 中华病理学杂志, 2018,47(10):758-762. doi:10.3760/cma.j.issn.0529-5807.2018.10.005
17 侯刚, 夏钰弘. 消化道炎性肌纤维母细胞瘤的CT表现与病理对照分析[J]. 实用医学杂志, 2013, 29(24):4082-4084. doi:10.3969/j.issn.1006-5725.2013.24.046
18 李太原,高庚妹. 胃肠道炎性肌纤维母细胞瘤的诊断与治疗策略[J]. 中华消化外科杂志, 2022, 21(8): 1038-1043. doi:10.3760/cma.j.cn115610-20220612-00323
19 MAKHLOUF H R, SOBIN L H. Inflammatory myofibroblastic tumors(inflammatory pseudotumors) of the gastrointestinal tract: how closely are they related to nflammatory fibroid polyps?[J]. Hum Pathol, 2002,33(3):307-315. doi:10.1053/hupa.2002.32213
20 徐艳松,路星,唐卫中. 结肠炎性肌纤维母细胞瘤临床分析[J]. 中华普通外科杂志,2014,29(3):220-222. doi:10.3760/cma.j.issn.1007-631X.2014.03.019
21 GURZU S, BARA T, JUNG I. Inflammatory myofibroblastic tumor of the colon[J], J Clin Oncol, 2013, 31(10): e155- e158. doi:10.1200/jco.2012.42.8961
22 张帆,焦南林,张伟,等. 肠系膜上皮样型炎性肌纤维母细胞瘤1例并文献复习[J]. 临床与实验病理学杂志,2016,32(2):175-179.
文章导航

/